HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corina Becker Selected Research

riociguat

4/2019Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.
1/2018Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.
3/2016Effects of omeprazole and aluminum hydroxide/magnesium hydroxide on riociguat absorption.
3/2016Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).
3/2016Pharmacokinetic interaction study between riociguat and the combined oral contraceptives levonorgestrel and ethinylestradiol in healthy postmenopausal women.
3/2016Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).
3/2016Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food.
3/2016Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
3/2016Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).
3/2016Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Corina Becker Research Topics

Disease

11Heart Failure
11/2023 - 11/2020
9Pulmonary Hypertension
01/2018 - 03/2016
5Pulmonary Arterial Hypertension
04/2019 - 03/2016
2Hypotension (Low Blood Pressure)
04/2019 - 03/2016
2Body Weight (Weight, Body)
03/2016 - 01/2014
1Erectile Dysfunction
01/2023
1Angina Pectoris
01/2022
1HIV Infections (HIV Infection)
04/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2016
1Neoplasms (Cancer)
01/2011

Drug/Important Bio-Agent (IBA)

14Soluble Guanylyl CyclaseIBA
11/2023 - 03/2016
11vericiguatIBA
11/2023 - 11/2020
10riociguatIBA
04/2019 - 03/2016
1Sildenafil Citrate (Viagra)FDA Link
01/2023
1DiureticsIBA
11/2022
1NitratesIBA
01/2022
1Nitroglycerin (Dynamite)FDA LinkGeneric
01/2022
1pro-brain natriuretic peptide (1-76)IBA
11/2021
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2021
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
03/2016
1EnzymesIBA
03/2016
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
03/2016
1SmokeIBA
03/2016
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2016
1Ketoconazole (Nizoral)FDA LinkGeneric
03/2016
1RivaroxabanIBA
01/2014
1ProdrugsIBA
01/2011
1raf KinasesIBA
01/2011

Therapy/Procedure

4Therapeutics
11/2021 - 03/2016
1Polypharmacy
11/2020
1Drug Therapy (Chemotherapy)
01/2011